When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
MYOV - Myovant conference call tomorrow on second Relugolix Phase 3
Myovant Sciences Ltd.
Myovant Sciences (NYSE:MYOV) will host a conference call tomorrow, July 23, at 8:30 am ET to discuss results from a second Phase 3 clinical trial, LIBERTY 2, evaluating relugolix combination therapy in women with uterine fibroids and heavy menstrual bleeding.
More news on: Myovant Sciences Ltd., Healthcare stocks news,